Work

Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression

Year: 2015

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2015.04.010

Authors: Igor Puzanov, Ravi K. Amaravadi, Grant A. McArthur, Keith T. Flaherty, Paul B. Chapman, Jeffrey A. Sosman, Antoni Ribas, Mark Shackleton, Patrick Hwu, Bartosz Chmielowski, Keith B. Nolop, Paul S. Lin, Kevin B. Kim

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Abramson Cancer Center, University of Pennsylvania, Peter MacCallum Cancer Centre, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, Plexxikon (United States)

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: F. Hoffmann-La Roche, Plexxikon, National Institutes of Health, National Cancer Institute

Awards: G111615301, Cancer Center Support Grant, Cancer Center Support Grant

OpenAlex ID: W1508281037

FWCI: 5.015

Cites: 29

Cited by: 75

Related to: 10